Healthcare & Life Sciences
Ncardia
Netherlandsncardia.com
Ncardia is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2015
Founded
2
Investors
About Ncardia
Based in the Netherlands, Ncardia is a startup founded in 2015. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Ncardia (formerly Pluriomics) develops fully functional human cell-based assay systems for drug discovery and development. The company uses proprietary stem-cell differentiation methods to produce high-performance cell types—such as Pluricyte cardiomyocytes—used in phenotypic assays for pharmaceutical research.
Explore Ncardia's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.